Featured
American Journal of Ophthalmology: Published May, 2023Glaucoma is a disease characterized
by progressive deterioration of the optic nerve and retinal nerve fiber
layer (RNFL) defect with corresponding visual field changes.Globally, both the prevalence of
chronic kidney disease (CKD) and glaucoma are rising rapidly. These 2 diseases
share a comm...
ADA: Diabetes Journals: Published June 2023Diabetes mellitus (DM) is one of the most important causes of
CKD. Moreover, both DM and CKD are important risk factors for cardiovascular
disease (CVD). Metformin is still the first-line drug for DM management. The
concern, of course, is an increased risk of metformin-associated lactic
acidosis (MALA)...
Effect of SGLT2 Inhibitors on Kidney and CV Events in Patients with Advanced Diabetic Kidney Disease
Diabetes Research and Clinical Practice: Published
on December,
2022Sodium-Glucose Transport Protein 2
(SGLT2) Inhibitors also called gliflozins are a class of medicine used to lower
high blood glucose levels in people with type 2 diabetes. Medicines in the
SGLT2 inhibitor class include Canagliflozin, Dapagliflozin, Empagliflozin, Ertugli...
AHA Journals: Hypertension: Published on May, 2022Diabetes is a strong risk factor
for end-stage renal disease (ESRD). Hypertension also plays a crucial role
in the development and progression of kidney failure. Blood pressure (BP)
rises with declining kidney function which in turn aggravates hypertension. Moreover, as chronic kidney disease
(C...